- Investing Ideas
- /
- U.S. Undervalued Stocks Based On Cash Flows
U.S. Undervalued Stocks Based On Cash Flows
Results
182
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
182 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
EVTC | US$33.34 | 3.0% | -13.8% | US$2.1b | US$39.40 | PE30.7x | E24.9% | 0.6% | Diversified Financials | ||
STKL | US$6.36 | 7.8% | 44.5% | US$745.2m | US$9.83 | PS1.1x | E157.4% | n/a | Food, Beverage & Tobacco | ||
FLNC | US$18.01 | 14.2% | -20.3% | US$3.1b | US$27.42 | PS1.1x | E105.2% | n/a | Capital Goods | ||
QNST | US$17.40 | 1.7% | 77.2% | US$942.5m | US$22.80 | PS1.6x | E116.1% | n/a | Media | ||
KSPI | US$128.12 | 4.2% | 41.3% | US$24.0b | US$147.58 | PE12.5x | E18.4% | 5.6% | Diversified Financials | ||
EQT | US$33.72 | 4.5% | -24.3% | US$19.1b | US$42.34 | PE28.8x | E40.5% | 1.9% | Energy | ||
MXL | US$12.79 | 9.5% | -43.7% | US$1.1b | US$21.33 | PS2.4x | E82.8% | n/a | Semiconductors | ||
ORCL | US$137.92 | 4.0% | 18.3% | US$378.8b | US$148.92 | PE36.3x | E15.9% | 1.2% | Software | ||
SRAD | US$11.51 | 1.9% | 0.3% | US$3.3b | US$14.48 | PE116.8x | E41.8% | n/a | Consumer Services | ||
OC | US$162.58 | 4.7% | 19.3% | US$13.9b | US$186.68 | PE13.4x | E16.7% | 1.5% | Capital Goods | ||
ZG | US$53.64 | 9.3% | 12.1% | US$12.3b | US$55.97 | PS6x | E67.3% | n/a | Real Estate Management and Development | ||
VCTR | US$52.60 | 10.3% | 58.1% | US$3.4b | US$53.38 | PE14.4x | E32.3% | 3.1% | Diversified Financials | ||
AVBH | US$19.19 | 2.3% | -12.6% | US$150.9m | US$23.50 | PB0.9x | E22.3% | n/a | Banks | ||
VTS | US$25.16 | 2.9% | 8.1% | US$733.5m | US$27.15 | PE27.3x | E47.8% | 8.3% | Energy | ||
AFYA | US$18.57 | 6.3% | 27.3% | US$1.6b | US$21.57 | PE16.4x | E20.3% | n/a | Consumer Services | ||
CTKB | US$5.53 | 5.7% | -31.2% | US$722.0m | US$8.70 | PS3.7x | E111.9% | n/a | Pharmaceuticals & Biotech | ||
PACS | US$39.82 | 23.1% | n/a | US$5.9b | US$38.71 | PE65.8x | E45.3% | 0% | Healthcare | ||
ENV | US$62.76 | 1.3% | 18.4% | US$3.5b | US$64.25 | PS2.7x | E72.8% | n/a | Software | ||
CADE | US$31.20 | 7.3% | 35.6% | US$5.6b | US$35.58 | PB1.1x | E73.5% | 3.2% | Banks | ||
PFIS | US$45.62 | 6.6% | 0.4% | US$454.0m | US$49.00 | PB1.3x | E103.3% | 5.4% | Banks | ||
BILL | US$50.78 | 9.2% | -52.8% | US$5.2b | US$74.32 | PS4.3x | E30.3% | n/a | Software | ||
LYV | US$96.53 | 5.4% | 15.0% | US$21.9b | US$116.67 | PE87x | E29.6% | n/a | Media | ||
VERX | US$35.95 | 0.9% | 65.3% | US$5.6b | US$41.00 | PE282.6x | E38.9% | n/a | Software | ||
SSB | US$92.29 | 5.9% | 28.8% | US$7.0b | US$106.53 | PB1.2x | E27.8% | 2.3% | Banks |